Viewpoint March 5, 2015 Impact of edoxaban label Inside Edge Consulting, Princeton atrial fibrillation, edoxaban, FDA, Healthcare, Marketing consultants, novel agents, Payers, Targeted therapy
Viewpoint February 19, 2015 Combinations and sequencing in cancer Inside Edge Consulting, Princeton American Society of Hematology, ASCO, ASH, hematology, Marketing consultants, novel agents, Oncology, Targeted therapy
Viewpoint February 5, 2015 Biologics for everyone? Inside Edge Consulting, Princeton Consultant group, Health economics, Healthcare consultants, Managed care, novel agents, PCSK9
